Sanofi (SNY)
Nasdaq · American depositary receipt
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow SNY in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on SNY and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
SNY at a glance
Key statistics
$99.20B
Market capitalization
- Previous close
- $41.40
- Open
- $41.20
- Day range
- $40.85 – $41.54
- Volume
- 1.70M
- Average volume (30 sessions)
- 3.27M
- Shares outstanding
- 2.42B
- Beta (1 year, vs SPY)
- 0.30
Where the price sits in its year
52-week range
14% of the range
- Below the 52-week high
- -22.2%
- Above the 52-week low
- +4.9%
Completed sessions through Oct 20, 2026
Technical snapshot
Below its 50-day and 200-day averages
- 20-day average
- $40.38+2.5%
- 50-day average
- $42.55-2.7%
- 200-day average
- $44.55-7.1%
Between the conventional 30 and 70 bands.
+5.8%
1 week
-2.6%
1 month
-5.5%
3 months
-14.6%
Year to date
-18.2%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with SNY
SNY on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on SNY.
See the plans →
Every planScreen names like SNY
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on SNY
Put SNY on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on SNY
See whether there is an open premium alert on SNY, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
SNY headlines
- Global Influenza Vaccine Market Report, 2026 Edition - Profiles GlaxoSmithKline, Pfizer, Sanofi, Moderna, and 9 Other Players
GlobeNewswire Inc. · Aug 7, 2026
- Communiqué de presse : Rapport financier semestriel 2026 de Sanofi
GlobeNewswire Inc. · Jul 30, 2026
- Press Release: Sanofi’s half-year financial report for 2026
GlobeNewswire Inc. · Jul 30, 2026
- Communiqué de presse: Sanofi annonce sa décision de ne pas soumettre l’amlitélimab dans la dermatite atopique à des évaluations réglementaires mondiales
GlobeNewswire Inc. · Jul 24, 2026
- Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
GlobeNewswire Inc. · Jul 24, 2026
- Communiqué de presse : La Fondation Sanofi ouvre un nouveau chapitre centré sur les générations futures
GlobeNewswire Inc. · Jun 25, 2026
- Press Release: Sanofi Foundation opens new chapter centered on future generations
GlobeNewswire Inc. · Jun 25, 2026
- Communiqué de presse : Wayrilz de Sanofi a été approuvé au Japon pour traiter la thrombocytopénie immunitaire
GlobeNewswire Inc. · Jun 23, 2026
SEC Form 4, most recent first
Insider filings
No insider transactions reported for SNY recently. ETFs and many foreign issuers do not file Form 4.
About Sanofi
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
- Exchange
- Nasdaq
- Security
- American depositary receipt
- Employees
- 74,846
- Listed since
- Jul 1, 2002
- Website
- sanofi.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.